Liabilities and Equity in GBP of TC BioPharm (Holdings) plc from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: GBP
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
TC BioPharm (Holdings) plc quarterly Liabilities and Equity history and change rate from Q4 2022 to Q4 2024.
  • TC BioPharm (Holdings) plc Liabilities and Equity for the quarter ending 31 Dec 2024 was £8.33M, a 6.75% decline year-over-year.
Liabilities and Equity, Quarterly (GBP)
Liabilities and Equity, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Quarterly Liabilities and Equity (GBP)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 8.33M -603K -6.75% 31 Dec 2024 20-F 09 May 2025
Q2 2024 6.87M 30 Jun 2024 6-K 25 Nov 2024
Q1 2024 7.26M 31 Mar 2024 10-Q 15 May 2024
Q4 2023 8.93M -2.36M -20.9% 31 Dec 2023 20-F 09 May 2025
Q4 2022 11.3M 31 Dec 2022 10-K 01 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.